8-KLeadership ChangesExhibits & Filings

CME GROUP INC. 8-K Report, Executive Changes (Mar 10, 2023)

Filed March 10, 2023For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on March 9, 2023, detailing significant executive compensation and a new severance program for U.S. employees. A key element is the compensation package for John W. Pietrowicz, who will transition from Chief Financial Officer (CFO) to Special Advisor effective April 1, 2023, remaining with the company until December 31, 2023. His compensation as Special Advisor includes a substantial base salary, bonus opportunity, and equity awards, alongside continued vesting of prior equity grants, indicating a structured and incentivized transition. Furthermore, CME Group has implemented a new, standardized severance plan for its U.S. employees, replacing previous executive and general employee plans. This new plan offers a defined severance schedule based on years of service, with varying maximums depending on the reason for termination (performance vs. position elimination). The severance benefits are contingent upon the employee signing a release of claims, aiming to provide a more consistent framework for employee departures while mitigating company risk.

Key Highlights

  • 1John W. Pietrowicz to transition from CFO to Special Advisor role on April 1, 2023, remaining until December 31, 2023.
  • 2Pietrowicz's Special Advisor compensation package includes $600,000 annual base salary, 100% target bonus, and 300% target annual equity award.
  • 3Pietrowicz remains eligible to vest in previously granted equity awards during his tenure as Special Advisor.
  • 4CME Group approved a new, consolidated severance plan for U.S. employees, effective March 7, 2023.
  • 5New Severance Plan offers two weeks of pay per year of service, with minimums and maximums (up to 52 weeks for position eliminations).
  • 6Involuntary terminations due to position elimination may include a severance payment in lieu of an annual bonus.
  • 7Severance benefits are contingent on employees executing a release of claims.

Frequently Asked Questions

The filing details Mr. Pietrowicz's compensation as a Special Advisor, which includes a $600,000 base salary, potential bonus, and equity awards. While this represents a significant compensation structure for his advisory role, it facilitates a smooth handover from his CFO duties. Investors should note this is a planned transition and the associated costs are outlined. The new severance plan will also have financial implications as it standardizes payouts for U.S. employee terminations.

CME Group is consolidating and standardizing its severance benefits for U.S. employees under a new plan. This likely aims to create a more consistent and equitable approach to severance across the organization, potentially simplifying administration and clarifying terms for both employees and the company, while ensuring appropriate protections are in place through the release of claims.

The new plan replaces two previous plans (one for eligible executives and one for general employees) with a single framework. Key changes include a defined severance schedule of two weeks per year of service (with specific minimums and maximums up to 52 weeks depending on termination reason) and eligibility for a bonus in lieu of severance for certain involuntary terminations due to position elimination. This offers a more structured and potentially generous benefit for some employees compared to the prior plans.

Mr. Pietrowicz's continued role as Special Advisor, despite retiring as CFO, suggests the company values his experience and knowledge during the transition period. This ensures continuity and allows for knowledge transfer to his successor, Ms. Fitzpatrick, likely minimizing disruption to financial operations and strategic initiatives. His compensation package reflects this continued engagement and the importance of his advisory capacity.